Short Interest in Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) Increases By 625.5%

Algernon Pharmaceuticals Inc. (OTCMKTS:AGNPF) saw a significant growth in short interest in the month of February. As of February 15th, there was short interest totalling 37,000 shares, a growth of 625.5% from the January 31st total of 5,100 shares. Based on an average daily trading volume, of 82,800 shares, the days-to-cover ratio is presently 0.4 days.

Algernon Pharmaceuticals Price Performance

OTCMKTS AGNPF remained flat at $0.06 during trading hours on Thursday. The company’s 50 day moving average is $0.06 and its two-hundred day moving average is $0.06. Algernon Pharmaceuticals has a 12 month low of $0.04 and a 12 month high of $0.12.

Algernon Pharmaceuticals Company Profile

Algernon Pharmaceuticals Inc operates as a clinical stage pharmaceutical development company. It focuses on the areas of non-alcoholic steatohepatitis, chronic kidney disease, inflammatory bowel disease, idiopathic pulmonary fibrosis, chronic cough, pancreatic and small cell lung cancer, and acute lung injury in Canada and Australia.